EUVIMEDEUVIMED entdecken
Open Access

Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment

Anqi Lin, Pengxi Ye, Zhengrui Li, Aimin Jiang, Zaoqu Liu, Quan Cheng, Jian Zhang, Peng Luo iD

Research · 2025-01 · 8

DOI: 10.34133/research.0723 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research, online erschienen am 03.06.2025. Verfasst von Anqi Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Donghai County People's Hospital-Jiangnan University Smart Healthcare Joint Laboratory, Donghai County People's Hospital (Affiliated Kangda College o…. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Guangdong Province, the National Natural Science Foundation of China, the Guangdong Basic and Applied Basic Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural killer (NK) cells, serving as pivotal mediators of innate immunity, play an important role in antitumor immunity. Immune checkpoint can be expressed on the surface of NK cells and meticulously regulates their activation states and effector functions through complex signaling networks. In recent years, tumor immunotherapy strategies focusing on NK cell immune checkpoints have demonstrated remarkable advancements. This review systematically elucidates the expression profiles, signaling pathways, and the immune checkpoint molecule regulatory mechanisms localized on the NK cell membrane (e.g., NKG2A, KIRs, and TIGIT) or intracellularly (e.g., BIM, Cbl-b, and EZH2) during tumor immune evasion. Particular attention is devoted to dissecting the regulatory mechanisms through which these immune checkpoint molecules influence NK cell-mediated cytotoxicity, cytokine secretion, proliferative capacity, and tunable modulation of NK cell immune checkpoint expression by diverse factors within the tumor microenvironment. Furthermore, this review comprehensively summarizes preclinical advancements in NK cell immune checkpoint blockade strategies, including single checkpoint blockade, combinatorial checkpoint approaches, and their integration with conventional therapeutic modalities. Additionally, emerging therapeutic advancements, such as gene-editing technologies and chimeric antigen receptor-NK (CAR-NK) cell therapy, are evaluated for their prospective applications in immunotherapy based on NK cells. By thoroughly elucidating the molecular regulatory networks underlying NK cell immune checkpoints and their mechanisms of action within the complex tumor microenvironment, this review aims to provide critical theoretical insights and translational foundations to foster the development of innovative tumor immunotherapy strategies, improvement of combination therapies, and realization of personalized precision medicine.

Autor:innen und Institutionen

  • Donghai County People's Hospital-Jiangnan University Smart Healthcare Joint Laboratory, Donghai County People's Hospital (Affiliated Kangda College of Nanjing Medical University); Department of Oncology, Zhujiang Hospit…
  • School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Department of Oral and Cranio-Maxillofacial Surgery, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shang…
  • Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
  • Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

ORCID-Profile: Peng Luo

Förderung

  • Natural Science Foundation of Guangdong Province
  • the National Natural Science Foundation of China
  • the Guangdong Basic and Applied Basic Research Foundation
  • the Science and Technology Program of Guangzhou
  • Hunan Youth Science and Technology Talent Project

Zitieren

APA

Lin, A., Ye, P., Li, Z., Jiang, A., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2025). Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment. Research, 8. https://doi.org/10.34133/research.0723

Vancouver

Lin A, Ye P, Li Z, Jiang A, Liu Z, Cheng Q, et al. Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment. Research. 2025;8. doi:10.34133/research.0723

BibTeX
@article{Lin2025,
  author = {Lin, Anqi and Ye, Pengxi and Li, Zhengrui and Jiang, Aimin and Liu, Zaoqu and Cheng, Quan and Zhang, Jian and Luo, Peng},
  title = {Natural Killer Cell Immune Checkpoints and Their Therapeutic Targeting in Cancer Treatment},
  journal = {Research},
  year = {2025},
  volume = {8},
  doi = {10.34133/research.0723}
}
Kostenlos starten →